Comparing the effectiveness of melatonin with placebo in reducing the level of interleukin-6 in operated infants.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200109046061N2

Enrollment

Registered

2023-07-21

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severity of inflammation in operated babies.

Interventions

Intervention 1: Intervention group: The melatonin used in this intervention is Emivital drops from Amin company and contains one milligram of melatonin in each cc. Intervention 2: Control group: Place

Eligibility

Sex/Gender

All

Age

1 Days to 30 Days

Inclusion criteria

Inclusion criteria: Age limit below one month Hospitalized for surgery Consent of the family to participate in the plan

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The effect of melatonin on reducing the level of interleukin 6. Timepoint: Day before surgery. Day three after surgery. Method of measurement: Kate Eliza.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElnaznobakht

Shahid Beheshti University of Medical Sciences

dr.elnaznobakht@gmail.com+98 21 8617 5194

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026